# Ginger Nausea Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/ginger-nausea-meta-analysis-evidence-review
Category: evidence-review
Summary: Ginger Nausea Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic 
Last reviewed: 2026-05-28
Reviewed by: Migaku Evidence Review
# Ginger Nausea Meta-analysis: What the Evidence Says

## Quick Answer

Ginger Nausea Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 systematic review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Comparative Effectiveness of Pharmacological and Non-Pharmacological Interventions for Nausea and Vomiting in Pregnancy: A Systematic Review and Network Meta-Analysis | systematic review | 1 | 2026-04-20 | 10.3390/nu18081293 |
| Pharmacological properties of ginger ( Zingiber officinale ): what do meta-analyses say? a systematic review | systematic review | 1 | 2025-07-30 | 10.3389/fphar.2025.1619655 |

## What The Sources Report

- The condition not only affects maternal health but also has significant psychosocial and economic consequences, including reduced quality of life, increased healthcare utilization, and loss of productivity. [Frivaldszky Lőrinc (2026); evidence level 1]
- In severe cases, NVP has been associated with adverse pregnancy outcomes such as low birth weight and preterm birth, emphasizing the need for effective management strategies. [Frivaldszky Lőrinc (2026); evidence level 1]
- This review summarizes evidence from meta-analyses examining its role in reducing inflammation, improving glycemic control in type 2 diabetes, combating oxidative stress, and managing pregnancy-associated nausea and vomiting. [Paudel Keshab Raj (2025); evidence level 1]
- In recent years, their popularity has grown based on the belief that they offer effective alternatives to synthetic pharmaceuticals and are associated with fewer adverse effects (;;;;;). [Paudel Keshab Raj (2025); evidence level 1]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For ginger nausea meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Frivaldszky Lőrinc (2026). Comparative Effectiveness of Pharmacological and Non-Pharmacological Interventions for Nausea and Vomiting in Pregnancy: A Systematic Review and Network Meta-Analysis. DOI: 10.3390/nu18081293. PMCID: PMC13118981. PMID: 42075106. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13118981/
- Paudel Keshab Raj (2025). Pharmacological properties of ginger ( Zingiber officinale ): what do meta-analyses say? a systematic review. DOI: 10.3389/fphar.2025.1619655. PMCID: PMC12343617. PMID: 40808693. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12343617/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.